Spot Trading’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$19.2M Sell
236,600
-45,200
-16% -$3.46M 0.33% 24
2017
Q2
$19.9M Buy
281,800
+46,500
+20% +$3.09M 0.39% 23
2017
Q1
$16M Sell
235,300
-30,800
-12% -$2.17M 0.53% 16
2016
Q4
$19.1M Buy
266,100
+115,700
+77% +$8.6M 0.45% 12
2016
Q3
$11.9M Buy
150,400
+78,600
+109% +$6.38M 0.24% 59
2016
Q2
$5.99M Sell
71,800
-101,700
-59% -$9.03M 0.1% 246
2016
Q1
$15.9M Buy
173,500
+91,600
+112% +$8.26M 0.28% 47
2015
Q4
$8.29M Sell
81,900
-44,800
-35% -$4.66M 0.09% 303
2015
Q3
$12.4M Sell
126,700
-97,800
-44% -$10.9M 0.12% 182
2015
Q2
$26.3M Sell
224,500
-44,900
-17% -$4.91M 0.24% 50
2015
Q1
$26.4M Sell
269,400
-375,700
-58% -$38.1M 0.26% 45
2014
Q4
$60.8M Buy
645,100
+251,800
+64% +$26M 0.38% 23
2014
Q3
$41.9M Buy
393,300
+86,500
+28% +$8.47M 0.21% 63
2014
Q2
$25.4M Buy
306,800
+160,000
+109% +$12.5M 0.12% 162
2014
Q1
$10.4M Buy
146,800
+8,300
+6% +$651K 0.06% 432
2013
Q4
$10.4M Sell
138,500
-75,600
-35% -$5.26M 0.06% 430
2013
Q3
$13.5M Buy
214,100
+4,200
+2% +$251K 0.08% 250
2013
Q2
$10.8M Buy
+209,900
New +$10.9M 0.07% 330

Other funds holding GILD

Spot Trading's GILD Position: Q3 2017 in Review

Spot Trading increased its Gilead Sciences (GILD) stake by 101% in Q3 2017, buying an estimated $15.5M and bringing the position to 401,976 shares worth $32.6M. The position accounts for 0.56% of the portfolio, ranked #9.

Spot Trading first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Spot Trading held 401,976 shares of Gilead Sciences worth $32.6M as of Q3 2017.
  • Spot Trading bought 202,237 Gilead Sciences shares in Q3 2017, an estimated $15.5M.
  • Gilead Sciences made up 0.56% of Spot Trading's portfolio in Q3 2017, its #9 holding.
  • Spot Trading first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.